Skip to main
TWST

TWST Stock Forecast & Price Target

TWST Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Twist Bioscience is expected to see significant growth due to their disruptive DNA synthesis platform and the growing demand for AI-driven orders. With their strong focus on cost efficiency and potential for expanding DNA manufacturing capacity, the company has the potential for significant gross margin expansion and reaching Adj. EBITDA breakeven by FY26. The stock has a potential upside from current levels based on their financial targets and potential for catalysts in the near future, making it an attractive buy.

Bears say

Twist Bioscience is currently experiencing positive momentum in their stock thanks to their recent advancements in AI-driven NGS and drug discovery, but this may not accurately reflect the long-term potential for the company. There are execution risks to consider, particularly around margins and operating leverage, and the company's profitability story depends on continued gross margin improvement and disciplined expense control. Furthermore, there are potential risks from slower market growth and competition that could negatively impact the company's future performance.

TWST has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Twist Bioscience Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Twist Bioscience Corp (TWST) Forecast

Analysts have given TWST a Buy based on their latest research and market trends.

According to 9 analysts, TWST has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Twist Bioscience Corp (TWST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.